Company intelligence
Institute for Clinical and Economic Review (ICER)
Working towards Fair Pricing, Fair Access, and Future Innovation
About Institute for Clinical and Economic Review (ICER)
The Institute for Clinical and Economic Review (ICER) is an independent, non-profit research institute that conducts evidence-based reviews of health care interventions, including prescription drugs, other treatments, and diagnostic tests. In collaboration with patients, clinical experts, and other key stakeholders, ICER analyzes the available evidence on the benefits and risks of these interventions to measure their value and suggest fair prices. ICER also regularly reports on the barriers to care for patients and recommends solutions to ensure fair access to prescription drugs. For more information about ICER, please visit www.icer.org.
Verified activity
Signals from Institute for Clinical and Economic Review (ICER)
2 published signals
Presence & Recognition
Institute for Clinical and Economic Review (ICER) President and CEO Sarah Emond will take the stage at the 2026 STATSummit in Boston this October alongside Gunnar Esiason and ed Silverman.
Reported by Institute for Clinical and Economic Review (ICER)
Partnerships
Institute for Clinical and Economic Review (ICER) and the West Health Policy Center announced a new collaboration to develop the 2026 Launch Price and Access Report, an independent analysis of drug prices and patient access for newly launched FDA-approved treatments.
Reported by Institute for Clinical and Economic Review (ICER)